|
|
 |
POVIDONE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
FD&C YELLOW NO. 5 Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
GLYCERIN Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SODIUM ACETATE ANHYDROUS Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|